Longitudinal Assessment of Genetic and Epigenetic Markers in Oligodendrogliomas

Iris Lavon, Daniel Zrihan, Bracha Zelikovitch, Yakov Fellig, Dana Fuchs, Dov Soffer, Tali Siegal

Clinical Cancer Research · 2007 · 43 citations · 30 references

Abstract

Pure oligodendrogliomas with 1p/19q deletion tend to retain their cell phenotype and genetic profile unlike tumors with no deletions or mixed histology. MGMT promoter methylation is more pronounced at tumor progression, particularly in tumors with an intact 1p. These observations suggest that MGMT promoter methylation is a late event in progressive oligodendrogliomas, and therefore, their chemosensitivity is not necessarily related to MGMT methylation status.

References

30